Epitomee Medical Ltd (TLV:EPIT)

Israel flag Israel · Delayed Price · Currency is ILS · Price in ILA
890.60
+10.90 (1.24%)
Mar 30, 2025, 3:49 PM IDT
174.71%
Market Cap 260.23M
Revenue (ttm) 37.17M
Net Income (ttm) 9.90M
Shares Out 29.58M
EPS (ttm) 0.32
PE Ratio 27.61
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 6,876
Average Volume 11,882
Open 879.70
Previous Close 879.70
Day's Range 841.60 - 899.90
52-Week Range 249.40 - 1,570.00
Beta 0.87
RSI 38.32
Earnings Date Mar 18, 2025

About Epitomee Medical

Epitomee Medical Ltd, a biomedical company, develops and commercializes ingestible therapeutic devices worldwide. Its capsule is used for weight management, waist circumference reduction, and cardiovascular risk factors reduction. Epitomee Medical Ltd has a strategic partnership with Nestlé Health Science S.A. for the development and commercialization of the weight loss capsule. The company was incorporated in 2005 and is based in Caesarea, Israel. [Read more]

Industry Medical Devices
Sector Healthcare
Founded 2005
Employees 42
Stock Exchange Tel Aviv Stock Exchange
Ticker Symbol EPIT
Full Company Profile

Financial Performance

Financial numbers in USD Financial Statements

News

There is no news available yet.